The Center for NeuroPotential (CNP) provides a holistic approach, bringing the heart and soul to neuroscience. Founded by Amy Palmer, Psy.D. (neuropsychologist) and Deb Del Vecchio-Scully ...
The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback